Achieving antral grinding forces in biorelevant in vitro models: comparing the USP dissolution apparatus II and the dynamic gastric model with human in vivo data.
作者信息
Vardakou Maria, Mercuri Annalisa, Barker Susan A, Craig Duncan Q M, Faulks Richard M, Wickham Martin S J
机构信息
Model Gut Platform, Institute of Food Research, Norwich Research Park, UK.
出版信息
AAPS PharmSciTech. 2011 Jun;12(2):620-6. doi: 10.1208/s12249-011-9616-z. Epub 2011 May 10.
Abstract
摘要
相似文献
1
Achieving antral grinding forces in biorelevant in vitro models: comparing the USP dissolution apparatus II and the dynamic gastric model with human in vivo data.
AAPS PharmSciTech. 2011 Jun;12(2):620-6. doi: 10.1208/s12249-011-9616-z. Epub 2011 May 10.
2
In vitro dissolution methodology, mini-Gastrointestinal Simulator (mGIS), predicts better in vivo dissolution of a weak base drug, dasatinib.
Eur J Pharm Sci. 2015 Aug 30;76:203-12. doi: 10.1016/j.ejps.2015.05.013. Epub 2015 May 12.
3
Validation of Dissolution Testing with Biorelevant Media: An OrBiTo Study.
Mol Pharm. 2017 Dec 4;14(12):4192-4201. doi: 10.1021/acs.molpharmaceut.7b00198. Epub 2017 Aug 23.
4
Hydrodynamics-induced variability in the USP apparatus II dissolution test.
Int J Pharm. 2005 Mar 23;292(1-2):17-28. doi: 10.1016/j.ijpharm.2004.08.003.
5
Assessment of antral grinding of a model solid meal with echo-planar imaging.
Am J Physiol Gastrointest Liver Physiol. 2001 May;280(5):G844-9. doi: 10.1152/ajpgi.2001.280.5.G844.
6
Development and application of a biorelevant dissolution method using USP apparatus 4 in early phase formulation development.
Mol Pharm. 2010 Oct 4;7(5):1466-77. doi: 10.1021/mp100125b. Epub 2010 Sep 2.
7
A biorelevant in vitro release/permeation system for oral transmucosal dosage forms.
Int J Pharm. 2012 Jul 1;430(1-2):104-13. doi: 10.1016/j.ijpharm.2012.03.050. Epub 2012 Apr 3.
8
A novel application of the T-cell for flow-through dissolution: the case of bioceramics used as ibuprofen carrier.
Talanta. 2009 Feb 15;77(4):1545-8. doi: 10.1016/j.talanta.2008.09.046. Epub 2008 Oct 5.
9
A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system.
Int J Pharm. 2004 Nov 22;286(1-2):99-109. doi: 10.1016/j.ijpharm.2004.08.007.
10
Hydrodynamic, mass transfer, and dissolution effects induced by tablet location during dissolution testing.
J Pharm Sci. 2009 Apr;98(4):1511-31. doi: 10.1002/jps.21512.
引用本文的文献
1
A Review on In Vitro Evaluation of Chemical and Physical Digestion for Controlling Gastric Digestion of Food.
Foods. 2025 Apr 21;14(8):1435. doi: 10.3390/foods14081435.
2
In Vitro-In Vivo Correlation Of Amorphous Solid Dispersion Enabled Itraconazole Tablets.
Pharm Res. 2025 Mar;42(3):485-502. doi: 10.1007/s11095-025-03837-z. Epub 2025 Mar 11.
3
Progress and challenges in designing dynamic gastric models to study food digestion.
Front Nutr. 2024 Jun 5;11:1399534. doi: 10.3389/fnut.2024.1399534. eCollection 2024.
4
Development of In Vitro Dissolution Testing Methods to Simulate Fed Conditions for Immediate Release Solid Oral Dosage Forms.
AAPS J. 2022 Mar 11;24(2):40. doi: 10.1208/s12248-022-00690-5.
5
Structure-function studies of chickpea and durum wheat uncover mechanisms by which cell wall properties influence starch bioaccessibility.
Nat Food. 2021 Feb;2(2):118-126. doi: 10.1038/s43016-021-00230-y. Epub 2021 Feb 18.
6
Seaweed Components as Potential Modulators of the Gut Microbiota.
Mar Drugs. 2021 Jun 23;19(7):358. doi: 10.3390/md19070358.
7
digestion models: a critical review for human and fish and a protocol for digestion in fish.
Bioengineered. 2021 Dec;12(1):3040-3064. doi: 10.1080/21655979.2021.1940769.
8
A review on the food digestion in the digestive tract and the used models.
Curr Res Food Sci. 2021 Apr 14;4:308-319. doi: 10.1016/j.crfs.2021.04.004. eCollection 2021.
9
IVIVC for Extended Release Hydrophilic Matrix Tablets in Consideration of Biorelevant Mechanical Stress.
Pharm Res. 2020 Oct 22;37(11):227. doi: 10.1007/s11095-020-02940-7.
10
Current Evidence on the Bioavailability of Food Bioactive Peptides.
Molecules. 2020 Sep 29;25(19):4479. doi: 10.3390/molecules25194479.
本文引用的文献
1
Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations.
Mol Pharm. 2009 Sep-Oct;6(5):1429-40. doi: 10.1021/mp9000876.
2
Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses.
Eur J Pharm Sci. 2009 Sep 10;38(2):147-55. doi: 10.1016/j.ejps.2009.06.010. Epub 2009 Jul 8.
3
Effect of intragastric acid stability of fat emulsions on gastric emptying, plasma lipid profile and postprandial satiety.
Br J Nutr. 2009 Mar;101(6):919-28. doi: 10.1017/S0007114508039986. Epub 2008 Aug 5.
4
Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
Eur J Pharm Biopharm. 2008 Oct;70(2):421-8. doi: 10.1016/j.ejpb.2008.05.029. Epub 2008 Jun 7.
5
Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update.
Pharm Res. 2008 Jul;25(7):1663-76. doi: 10.1007/s11095-008-9569-4. Epub 2008 Apr 11.
6
The gastric emptying of food as measured by gamma-scintigraphy and electrical impedance tomography (EIT) and its influence on the gastric emptying of tablets of different dimensions.
J Pharm Pharmacol. 2007 Nov;59(11):1527-36. doi: 10.1211/jpp.59.11.0010.
7
Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers.
J Pharm Pharmacol. 2007 Jul;59(7):941-5. doi: 10.1211/jpp.59.7.0005.
8
The influence of non-disintegrating tablet dimensions and density on their gastric emptying in fasted volunteers.
J Pharm Pharmacol. 2007 Jan;59(1):23-7. doi: 10.1211/jpp.59.1.0004.
9
Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications.
Eur J Pharm Sci. 2006 Feb;27(2-3):259-67. doi: 10.1016/j.ejps.2005.10.007. Epub 2005 Nov 28.
10
Impact of the intragastric location of extended release tablets on food interactions.
J Control Release. 2005 Nov 28;108(2-3):375-85. doi: 10.1016/j.jconrel.2005.08.018. Epub 2005 Oct 5.
Zotero 插件